Under the deal, AmerisourceBergen will pay Walgreens Boots Alliance $6.275 billion in cash and 2 million shares of its common stock.
The companies said the transaction will allow AmerisourceBergen to provide more global support to pharmacies and drugmakers and let Walgreens Boots Alliance focus on strengthening its retail pharmacy businesses.
The deal is expected to close by the end of AmerisourceBergen’s 2021 fiscal year.
More articles on pharmacy:
Cuomo proposes making it a crime to skip ahead in COVID-19 vaccination line
Pfizer CMO departs; replacement named
FDA: Not enough data to halve COVID-19 vaccine doses
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.